Long Non-Coding RNA GATA6-AS1 Sponges miR-324-5p to Inhibit Lung Cancer Cell Proliferation and Invasion

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Thomson CS, Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer. 2009;101(Suppl 2):S102109. doi:10.1038/sj.bjc.6605399
   Google Scholar
• Sun M, Liu XH, Wang KM, et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer. 2014;13:68. doi:10.1186/1476-4598-13-6824655544
   PubMed Web of Science ®Google Scholar
• Vitiello M, Tuccoli A, Poliseno L. Long non-coding RNAs in cancer: implications for personalized therapy. Cell Oncol. 2015;38(1):17–28. doi:10.1007/s13402-014-0180-x
   PubMed Web of Science ®Google Scholar
• Adelman K, Egan E. Non-coding RNA: more uses for genomic junk. Nature. 2017;543(7644):183–185. doi:10.1038/543183a28277509
   PubMed Web of Science ®Google Scholar
• Costa FF. Non-coding RNAs, epigenetics and complexity. Gene. 2008;410(1):9–17. doi:10.1016/j.gene.2007.12.00818226475
   PubMed Web of Science ®Google Scholar
• Pecero ML, Salvador-Bofill J, Molina-Pinelo S. Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer. Cell Oncol. 2019;42(1):1–12. doi:10.1007/s13402-018-0412-6
   Web of Science ®Google Scholar
• Abdollahzadeh R, Daraei A, Mansoori Y, Sepahvand M, Amoli MM, Tavakkoly-Bazzaz J. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer. J Cell Physiol. 2019;234(7):10080–10100. doi:10.1002/jcp.2794130537129
   PubMed Web of Science ®Google Scholar
• Wang LX, Wan C, Dong ZB, Wang BH, Liu HY, Li Y. Integrative analysis of long noncoding RNA (lncRNA), microRNA (miRNA) and mRNA expression and construction of a competing endogenous RNA (ceRNA) network in metastatic melanoma. Med Sci Monit. 2019;25:2896–2907. doi:10.12659/MSM.91388131004080
   PubMed Web of Science ®Google Scholar
• Liang T, Zhou B, Shi L, et al. lncRNA AK017368 promotes proliferation and suppresses differentiation of myoblasts in skeletal muscle development by attenuating the function of miR-30c. FASEB J. 2018;32(1):377–389. doi:10.1096/fj.201700560rr28904016
   PubMed Web of Science ®Google Scholar
• Rossi M, Bucci G, Rizzotto D, et al. LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-beta. Nat Commun. 2019;10(1):1969. doi:10.1038/s41467-019-09754-131036808
   PubMedGoogle Scholar
• Hu B, Zhang H, Wang Z, Zhang F, Wei H, Li L. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4. Cancer Biol Ther. 2017;18(12):974–983. doi:10.1080/15384047.2017.138567929020498
   PubMed Web of Science ®Google Scholar
• Jiao P, Hou J, Yao M, Wu J, Ren G. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer. Biomed Pharmacother. 2019;117:109164. doi:10.1016/j.biopha.2019.10916431252267
   PubMed Web of Science ®Google Scholar
• Li N, Gao WJ, Liu NS. LncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transition. Eur Rev Med Pharmacol Sci. 2017;21(9):2075–2086.28537678
   PubMed Web of Science ®Google Scholar
• Liu L, Zhou XY, Zhang JQ, et al. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway. Eur Rev Med Pharmacol Sci. 2018;22(24):8722–8730. doi:10.26355/eurrev_201812_1663730575912
   PubMed Web of Science ®Google Scholar
• Xie X, Liu HT, Mei J, et al. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis. Int J Clin Exp Pathol. 2014;7(12):8881–8886.25674259
   PubMed Web of Science ®Google Scholar
• Li ZT, Zhang X, Wang DW, et al. Overexpressed lncRNA GATA6-AS1 Inhibits LNM and EMT via FZD4 through the Wnt/beta-catenin signaling pathway in GC. Mol Ther Nucleic Acids. 2019;19:827–840. doi:10.1016/j.omtn.2019.09.03431981860
   PubMedGoogle Scholar
• Xiong Y, Zhang X, Lin Z, et al. SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma. Oncol Lett. 2019;18(4):3985–3993. doi:10.3892/ol.2019.1074431579094
   PubMed Web of Science ®Google Scholar
• Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development. 2005;132(21):4653–4662. doi:10.1242/dev.0207316224045
   PubMed Web of Science ®Google Scholar
• Bian HB, Pan X, Yang JS, Wang ZX, De W. Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549). J Exp Clin Cancer Res. 2011;30:20. doi:10.1186/1756-9966-30-2021329503
   PubMed Web of Science ®Google Scholar
• Lin MH, Chen YZ, Lee MY, et al. Comprehensive identification of microRNA arm selection preference in lung cancer: miR-324-5p and −3p serve oncogenic functions in lung cancer. Oncol Lett. 2018;15(6):9818–9826. doi:10.3892/ol.2018.855729844840
   PubMed Web of Science ®Google Scholar
• Ba Z, Zhou Y, Yang Z, Xu J, Zhang X. miR-324-5p upregulation potentiates resistance to cisplatin by targeting FBXO11 signalling in non-small cell lung cancer cells. J Biochem. 2019;166(6):517–527. doi:10.1093/jb/mvz06631778188
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• Jin Y, Shenoy AK, Doernberg S, et al. FBXO11 promotes ubiquitination of the Snail family of transcription factors in cancer progression and epidermal development. Cancer Lett. 2015;362(1):70–82. doi:10.1016/j.canlet.2015.03.03725827072
   PubMed Web of Science ®Google Scholar
• Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K. The emerging role of lncRNAs in the regulation of cancer stem cells. Cell Oncol. 2018;41(6):585–603. doi:10.1007/s13402-018-0406-4
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang Y, Zhang W, Li J, Liu W, Lu W. Long non-coding RNA SNHG14 exerts oncogenic functions in non-small cell lung cancer through acting as an miR-340 sponge. Biosci Rep. 2019;39:1.
   Web of Science ®Google Scholar
• Zhang X, Zhang L, Chen M, Liu D. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression. Artif Cells Nanomed Biotechnol. 2020;48(1):315–324. doi:10.1080/21691401.2019.170372431858815
   PubMed Web of Science ®Google Scholar
• Gu C, Zhang M, Sun W, Dong C. Upregulation of miR-324-5p inhibits proliferation and invasion of colorectal cancer cells by targeting ELAVL1. Oncol Res. 2019;27(5):515–524. doi:10.3727/096504018X1516618359857229386086
   PubMed Web of Science ®Google Scholar